Palouse Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Palouse Capital Management, Inc.

$154 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $2.97 Million - $3.35 Million	-51,536 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $75,469 - $94,571	1,303 Added 2.59%	51,536 $3.06 Million
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $69,940 - $79,383	-1,078 Reduced 2.1%	50,233 $3.65 Million
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $87,726 - $94,646	-1,296 Reduced 2.46%	51,311 $3.58 Million
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $28,180 - $30,791	-444 Reduced 0.84%	52,607 $3.62 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $96,120 - $109,672	-1,602 Reduced 2.93%	53,051 $3.43 Million
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $1.82 Million - $2.08 Million	-32,153 Reduced 37.04%	54,653 $3.18 Million
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $516,361 - $649,235	8,315 Added 10.59%	86,806 $5.49 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $232,428 - $269,892	-3,213 Reduced 3.93%	78,491 $6.04 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $226,908 - $290,637	3,623 Added 4.64%	81,704 $6.11 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $764,334 - $840,743	-12,404 Reduced 13.71%	78,081 $5.07 Million
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $82,638 - $91,218	-1,322 Reduced 1.44%	90,485 $5.74 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $67,809 - $76,040	-1,096 Reduced 1.18%	91,807 $6.2 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $664,006 - $743,860	10,619 Added 12.91%	92,903 $6.04 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $618,355 - $806,906	-10,214 Reduced 11.04%	82,284 $5.15 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $32,503 - $35,987	456 Added 0.5%	92,498 $7.14 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $86,355 - $100,730	-1,331 Reduced 1.43%	92,042 $6.52 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $21,997 - $26,817	302 Added 0.32%	93,373 $7.04 Million
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $36,357 - $42,678	511 Added 0.55%	93,071 $6.67 Million
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $6.67 Million - $7.91 Million	92,560	92,560 $7.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.

Account